The Dana-Farber CISNET Model for Breast Cancer Screening Strategies: An Update

Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling

(2018) Jeanne S. Mandelblatt et al.   MEDICAL DECISION MAKING

Modeling Ductal Carcinoma In Situ (DCIS): An Overview of CISNET Model Approaches

(2018) Nicolien T. van Ravesteyn et al.   MEDICAL DECISION MAKING

Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies

(2016) Jeanne S. Mandelblatt et al.   ANNALS OF INTERNAL MEDICINE

Cancer statistics: Breast cancer in situ

(2015) Elizabeth M. Ward et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The Contribution of Mammography Screening to Breast Cancer Incidence Trends in the United States: An Updated Age-Period-Cohort Model

(2015) R. E. Gangnon et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Rethinking the Standard for Ductal Carcinoma In Situ Treatment

(2015) Laura Esserman et al.   JAMA Oncology

Benefits, Harms, and Costs for Breast Cancer Screening After US Implementation of Digital Mammography

(2014) Natasha K. Stout et al.   JNCI-Journal of the National Cancer Institute

Effects of Screening and Systemic Adjuvant Therapy on ER-Specific US Breast Cancer Mortality

(2014) Diego Munoz et al.   JNCI-Journal of the National Cancer Institute

Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years

(2013) Nicolien T. van Ravesteyn   ANNALS OF INTERNAL MEDICINE

The Changing Incidence of In situ and Invasive Ductal and Lobular Breast Carcinomas: United States, 1999-2004

(2009) C. R. Eheman et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Lobular neoplasia on core needle biopsy does not require excision

(2008) Chandandeep S. Nagi et al.   CANCER

Mortality Modeling of Early Detection Programs

(2007) Sandra J. Lee et al.   BIOMETRICS